AnaptysBio (ANAB) Shares Rise After GSK's FDA Label Expansion for Jemperli

gurufocus.com · 2026-10-19

On October 19, 2026, AnaptysBio Inc (NASDAQ: ANAB) experienced a notable uptick in its share price following the announcement that its partner, GSK, received FD

Read the full story at gurufocus.com →